GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amarin Corp PLC (STU:EH3) » Definitions » Cyclically Adjusted Price-to-FCF

Amarin (STU:EH3) Cyclically Adjusted Price-to-FCF : (As of Jun. 05, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Amarin Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Amarin Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Amarin's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amarin Cyclically Adjusted Price-to-FCF Chart

Amarin Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Amarin Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Amarin's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - General subindustry, Amarin's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amarin's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amarin's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Amarin's Cyclically Adjusted Price-to-FCF falls into.


;
;

Amarin Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Amarin's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Amarin's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.558/123.4051*123.4051
=-0.558

Current CPI (Mar. 2025) = 123.4051.

Amarin Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -2.530 100.573 -3.104
201509 -2.193 100.274 -2.699
201512 -2.325 99.676 -2.878
201603 -2.432 99.676 -3.011
201606 -0.856 101.072 -1.045
201609 -1.595 100.274 -1.963
201612 -1.358 99.676 -1.681
201703 -0.964 100.374 -1.185
201706 -0.691 100.673 -0.847
201709 -0.389 100.474 -0.478
201712 -0.133 100.075 -0.164
201803 -0.558 100.573 -0.685
201806 -1.425 101.072 -1.740
201809 -1.633 101.371 -1.988
201812 -1.806 100.773 -2.212
201903 -2.051 101.670 -2.489
201906 0.851 102.168 1.028
201909 1.125 102.268 1.358
201912 -0.448 102.068 -0.542
202003 0.195 102.367 0.235
202006 0.071 101.769 0.086
202009 0.473 101.072 0.578
202012 -1.613 101.072 -1.969
202103 -0.796 102.367 -0.960
202106 -0.622 103.364 -0.743
202109 -0.195 104.859 -0.229
202112 -1.182 106.653 -1.368
202203 -4.512 109.245 -5.097
202206 -3.069 112.779 -3.358
202209 -0.909 113.504 -0.988
202212 0.072 115.436 0.077
202303 -0.322 117.609 -0.338
202306 0.326 119.662 0.336
202309 0.336 120.749 0.343
202312 -0.029 120.749 -0.030
202403 -0.565 120.990 -0.576
202406 -0.124 122.318 -0.125
202409 -0.103 121.594 -0.105
202412 -0.618 122.439 -0.623
202503 -0.558 123.405 -0.558

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Amarin  (STU:EH3) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Amarin Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Amarin's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Amarin Business Description

Industry
Traded in Other Exchanges
Address
One Central Plaza, 36 Dame Street, 5th Floor, Dublin, IRL, 02
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Amarin Headlines

No Headlines